Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study

Demirci I., Haymana C., Tasci I., Satman I., ATMACA A., ŞAHİN M., ...Daha Fazla

ENDOKRYNOLOGIA POLSKA, cilt.73, sa.1, ss.87-95, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 73 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5603/epa2022.0008
  • Dergi Adı: ENDOKRYNOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.87-95
  • Anahtar Kelimeler: COVID-19, coronavirus, type 1 diabetes, mortality, diabetes mellitus, T1DM, Turkey, CLINICAL CHARACTERISTICS, HOSPITALIZED-PATIENTS, RISK-FACTORS, SEVERITY, DISEASE, PNEUMONIA, ADULTS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM) are lacking. The purpose of this study was to find out the relative clinical severity and mortality of COVID-19 patients with T1DM and T2DM.